We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$80.5M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$57.6M -$125K -13,300 -0.2%
Capital World Investors
3
Capital World Investors
California
$37.5M
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$12.6M +$3.77M +400,000 +35%
FCMI
5
Foresite Capital Management II
California
$8.6M -$6.66M -706,703 -40%
QF
6
QVT Financial
New York
$6.39M
RSCM
7
Rock Springs Capital Management
Maryland
$6.24M
Fidelity International
8
Fidelity International
Bermuda
$6.14M
O
9
OrbiMed
New York
$5.9M +$2.69M +285,400 +65%
Millennium Management
10
Millennium Management
New York
$5.5M -$2.28M -241,784 -26%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$4.29M -$70.8K -7,520 -1%
RG
12
Rathbones Group
United Kingdom
$3.67M +$2.35M +250,000 +125%
Baillie Gifford & Co
13
Baillie Gifford & Co
United Kingdom
$3.5M
Jennison Associates
14
Jennison Associates
New York
$3.28M -$3.37K -358 -0.1%
TCM
15
Tekla Capital Management
Massachusetts
$2.42M
A
16
Abingworth
United Kingdom
$2.03M
AC
17
Ascend Capital
California
$1.75M +$1.55M +164,794 +330%
IHM
18
Iguana Healthcare Management
New York
$1.63M -$471K -50,000 -20%
Renaissance Technologies
19
Renaissance Technologies
New York
$1.54M +$716K +76,000 +67%
NLVP
20
New Leaf Venture Partners
New York
$1.03M +$1.2M +127,041 New
Zurich Cantonal Bank
21
Zurich Cantonal Bank
Switzerland
$888K +$33.1K +3,519 +3%
BBA
22
Baker Bros. Advisors
New York
$815K
VIA
23
Vident Investment Advisory
Georgia
$600K -$636K -67,514 -48%
State Street
24
State Street
Massachusetts
$536K
WMSA
25
Weiss Multi-Strategy Advisers
New York
$535K -$418K -44,390 -40%